COGT
Price
$4.37
Change
+$0.09 (+2.11%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
486.14M
26 days until earnings call
TSHA
Price
$1.24
Change
+$0.06 (+5.08%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
241.9M
20 days until earnings call
Ad is loading...

COGT vs TSHA

Header iconCOGT vs TSHA Comparison
Open Charts COGT vs TSHABanner chart's image
Cogent Biosciences
Price$4.37
Change+$0.09 (+2.11%)
Volume$55.65K
Capitalization486.14M
Taysha Gene Therapies
Price$1.24
Change+$0.06 (+5.08%)
Volume$24.43K
Capitalization241.9M
COGT vs TSHA Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. TSHA commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (COGT: $4.27 vs. TSHA: $1.18)
Brand notoriety: COGT and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 170% vs. TSHA: 40%
Market capitalization -- COGT: $486.14M vs. TSHA: $241.9M
COGT [@Biotechnology] is valued at $486.14M. TSHA’s [@Biotechnology] market capitalization is $241.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than TSHA.

Price Growth

COGT (@Biotechnology) experienced а -4.26% price change this week, while TSHA (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.98%. For the same industry, the average monthly price growth was -13.73%, and the average quarterly price growth was -24.94%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

TSHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+6.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($486M) has a higher market cap than TSHA($242M). TSHA YTD gains are higher at: -31.792 vs. COGT (-45.256). TSHA has higher annual earnings (EBITDA): -87.95M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. TSHA (139M). COGT has less debt than TSHA: COGT (17.5M) vs TSHA (63.2M). TSHA has higher revenues than COGT: TSHA (8.33M) vs COGT (0).
COGTTSHACOGT / TSHA
Capitalization486M242M201%
EBITDA-271.59M-87.95M309%
Gain YTD-45.256-31.792142%
P/E RatioN/A2.70-
Revenue08.33M-
Total Cash287M139M206%
Total Debt17.5M63.2M28%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTTSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
83%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEMAX19.77N/A
N/A
Neuberger Berman Emerg Mkts Eq A
DRGVX42.80N/A
N/A
BNY Mellon Dynamic Value Fund I
JCVCX21.30N/A
N/A
JHancock Classic Value C
IVAEX21.56N/A
N/A
Macquarie Asset Strategy Fund Cl I
ZSCCX26.38N/A
N/A
Zacks Small-Cap Core Inv

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-7.09%
LOGC - TSHA
45%
Loosely correlated
-3.10%
ALT - TSHA
39%
Loosely correlated
-2.87%
VYGR - TSHA
38%
Loosely correlated
-2.49%
TRDA - TSHA
37%
Loosely correlated
-0.13%
COGT - TSHA
37%
Loosely correlated
-12.32%
More